
|Articles|January 20, 2015
Covance Solution Bridges Preclinical to Clinical Development
Covance Inc., the world’s most comprehensive drug development company, today announced the introduction of Covance Early Phase Development Solutions,
Advertisement
Covance has introduced its Early Phase Development Solutions, a multi-disciplined approach to early drug development that provides sponsors access to a molecule solution team made up of experts from nonclinical, clinical and regulatory disciplines. These experts will focus on the sponsor’s unique target product profile to provide ongoing continuity in strategic program design that spans nonclinical through to first-in-human ready, Phase II ready, proof-of-concept and full-development ready.
Read the full text
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
3
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5




